QTTB Q32 Bio Inc: Earnings per share for the last twelve months
Precision drug logistics minimize supply disruptions, yet the rolling 12-month earnings per share trend for Q32 Bio Inc. (QTTB) on GURU.Markets reflects market volatility, where 3.34 captures the magnitude of this parameter. Scientific alliances in the fight against renal pathologies, along with robust patent protection and the complexity of navigating FDA filters, ensure stability by creating insurmountable barriers to entry for new players.
Analytical breakdowns and data insights for company Q32 Bio Inc (QTTB)
- current quotes and average value forecast:
- company stock capitalization data:
- shareholders' equity book value data:
- debt and liquidity data:
- earnings and valuation multiples indicators:
QTTB - Company Net Income|Projected Future Earnings Q32 Bio Inc.|QTTB - Business Payback Period|Future Price to Earnings Q32 Bio Corp|QTTB - Price to Earnings Adjusted for Growth Rate|Enterprise Value to EBITDA Ratio Q32 Bio Inc.|QTTB - Income before deduction of interest, taxes and amortization|Net earnings per share (EPS TTM) Q32 Bio|QTTB - Net earnings per share for the last four quarters|Year-over-year earnings per share growth for the last twelve months q32bio.com|QTTB - Earnings per share growth this year|Earnings growth forecast for next year Q32 Bio Inc.
- sales and revenue data:
Comprehensive company analysis:q32bio.com - QTTB
As a portfolio manager, I view this indicator as the final filter for capital efficiency. The metric is calculated by dividing total annual net income by the total number of shares, reflecting the actual income per share. By analyzing the current trailing 12-month EPS, an investor assesses the business's ability to generate cash flow. For Q32 Bio Inc. (QTTB), this figure demonstrates a transition stage from R&D expenditures to patent monetization. The high margins of antibodies should transform the price action on this chart into sustainable growth in the future.
Competitor analysis for Q32 Bio Inc.
ARGX - Earnings per share for the last twelve months|biontech.de (BNTX) - Net earnings per share for the last 12 months|Abivax Pharma (ABVX) - Earnings per share for the last twelve months|Net earnings per share for the last 12 months ADMA Biologics Inc|Net earnings per share for the last 12 months PTGX|Net earnings per share (EPS TTM) Immunovant Therapeutics|Earnings per share for the last twelve months Kiniksa Pharmaceuticals (KNSA)|grifols.com - Earnings per share for the last 12 months|Net earnings per share (EPS TTM) ADPT (Adaptive Biotechnologies Corporation)|Celldex Therapeutics Inc (CLDX) - Net earnings per one share for the last twelve months|AUPH - Earnings per share for the last twelve months|Net earnings per share for the trailing year BioCryst Corp (BCRX)|VERA (Vera Therapeutics, Inc.) - Net earnings per share for the last 12 months|DNTH (dianthustx.com) - Earnings per share for the last twelve months|Net earnings per share for the last 12 months PHVS|ABCL: Earnings per share for the trailing year|Net earnings per share (EPS TTM) TRML|Earnings per share for the last twelve months PGEN (Precigen Corp)|Net earnings per share (EPS TTM) PHAR (Pharming Group N.V.)|Net earnings per share for the last four quarters nektar.com (NKTR)|UPB - Earnings per share for the last twelve months|Net earnings per one share for the last twelve months Zenas Bio|IMNM (Immunome Corp) - Net earnings per share for the last 12 months|Gossamer Bio Corp. - Earnings per share for the trailing year|KALV (KalVista Pharmaceuticals) - Net earnings per share (EPS TTM)|septerna.com (SEPN) - Net earnings per share for the last four quarters|Earnings per share for the last twelve months Pieris Pharmaceuticals, Inc. (PVLA)|Savara Inc - Earnings per share for the last 12 months|Net earnings per share (EPS TTM) RIGL (Rigel Pharmaceuticals Inc)|ANAB - Net earnings per share for the last 12 months|ATXS: Net earnings per share for the last 12 months|Net earnings per share for the last four quarters engene.com ENGN|RAPT Therapeutics, Inc. (RAPT) - Earnings per share for the last twelve months|Net earnings per share for the trailing year Aerovate Therapeutics JBIO|Net earnings per share for the last 12 months ACRS|KYTX (Kyverna Therapeutics, Inc) - Earnings per share for the last four quarters|Net earnings per share for the last 12 months TLSA (Tiziana Life Sciences)|Earnings per share for the last four quarters CABA|Net earnings per share (EPS TTM) VTYX (Ventyx Biosciences, Inc.)|Theratechnologies, Inc. - Earnings per share for the last twelve months|AVTX - Earnings per share for the last twelve months|Earnings per one share for the last 12 months ELDN|AGEN: Net earnings per share (EPS TTM)|climbbio.com - Earnings per share for the trailing year|ZURA (Zura Bio Limited) - Net earnings per share (EPS TTM)|Net earnings per share (EPS TTM) aTyr Pharma Inc|Earnings per share for the last twelve months Adagene (ADAG)|IMA (ikenaoncology.com) - Earnings per share for the trailing year|Earnings per share for the last twelve months Shattuck Labs STTK|EQ - Net earnings per share for the last 12 months|Connect Pharma - Net earnings per share (EPS TTM)|IMUX - Net earnings per share (EPS TTM)|ATRA (atarabio.com) - Net earnings per share for the last 12 months|InflaRx - Earnings per share for the trailing year|XFOR (X4 Pharmaceuticals) - Net earnings per share (EPS TTM)|Adicet (ACET) - Net earnings per share for the last four quarters|Earnings per share for the last twelve months Celularity Inc. (CELU)|Net earnings per share for the last 12 months INmune Bio Inc INMB|Earnings per share for the last twelve months Barinthus Bio BRNS|KZR - Net earnings per share for the last 12 months|SABS: Net earnings per share for the last 12 months|AKTX - Net earnings per share (EPS TTM)|enlivex.com (ENLV) - Earnings per share for the last twelve months|Earnings per share for the last 12 months GOVX|EDSA (Edesa) - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months iBio Corporation IBIO|Earnings per share for the last twelve months Carisma Therapeutics (CARM)|xtlbio.com (XTLB) - Net earnings per share for the trailing year|Bolt Biotherapeutics, Inc. - Net earnings per share for the last 12 months|HCW Biologics, Inc. - Earnings per share for the last twelve months|APVO: Net earnings per share for the last 12 months|Earnings per share for the trailing year AIM (AIM ImmunoTech, Inc.)|ADTX: Net earnings per share (EPS TTM)|GRI (gribio.com) - Earnings per share for the last twelve months|XRTX (XORTX Therapeutics) - Net earnings per share (EPS TTM)|Vyome Holdings Inc. (HIND) - Net earnings per share for the last four quarters|Earnings per share for the last twelve months Revelation Bio (REVB)|INDP - Net earnings per one share for the last twelve months|Scinai Immunotherapeutics - Net earnings per share for the last 12 months|Earnings per share for the trailing year CALI|Affimed Therapeutics - Net earnings per share (EPS TTM)|Net earnings per share for the last four quarters Allakos Inc. ALLK|hookipapharma.com (HOOK) - Earnings per share for the last twelve months|Earnings per share for the last 12 months IGMS|ITOS (iTeos Therapeutics) - Net earnings per share (EPS TTM)|Net earnings per share for the last 12 months oceanbiomedical.com (OCEA)|Net earnings per share for the last 12 months TCBP (TC BioPharm)|Net earnings per share for the last four quarters Third Harmonic Bio Inc.
